Beyfortus approved in China for the prevention of RSV disease in infants

eAwazMedicine

London – AstraZeneca and Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in neonates and infants entering or during their first RSV season.1 Beyfortus is anticipated to be available during the upcoming 2024-2025 RSV season. Beyfortus is the first approved preventive option to protect against RSV in a …

N. Vancouver firm receives over $2m to market welding robots globally

eAwazLocal News

The Government of Canada is making investments in British Columbia to fuel economic growth and support high-tech manufacturers to increase their global sales North Vancouver – Across B.C., innovative companies are creating technologies to solve the challenges facing manufacturers across the globe. In North Vancouver, Novarc Technologies Inc. is developing a unique automation solution to help solve the global manufacturing …